메뉴 건너뛰기




Volumn 14, Issue 6, 2013, Pages 11145-11156

Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC patients

Author keywords

CA125; Lung cancer; NSE; SCC; Tumor marker

Indexed keywords

CA 125 ANTIGEN; NEURON SPECIFIC ENOLASE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; ENOLASE; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

EID: 84878444832     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140611145     Document Type: Article
Times cited : (66)

References (36)
  • 2
    • 58149132633 scopus 로고    scopus 로고
    • Locally advanced non-small cell lung cancer: The past, present, and future
    • Govindan, R.; Bogart, J.; Vokes, E.E. Locally advanced non-small cell lung cancer: The past, present, and future. J. Thorac. Oncol. 2008, 3, 917-928.
    • (2008) J. Thorac. Oncol. , vol.3 , pp. 917-928
    • Govindan, R.1    Bogart, J.2    Vokes, E.E.3
  • 3
    • 24344501624 scopus 로고    scopus 로고
    • Pathogenesis of lung cancer: 100 year report
    • Miller, Y.E. Pathogenesis of lung cancer: 100 year report. Am. J. Respir. Cell Mol. Biol. 2005, 33, 216-223.
    • (2005) Am. J. Respir. Cell Mol. Biol. , vol.33 , pp. 216-223
    • Miller, Y.E.1
  • 4
    • 77958190279 scopus 로고    scopus 로고
    • Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer
    • Barak, V.; Holdenrieder, S.; Nisman, B.; Stieber, P. Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer. Cancer Biomark. 2010, 6, 191-196.
    • (2010) Cancer Biomark. , vol.6 , pp. 191-196
    • Barak, V.1    Holdenrieder, S.2    Nisman, B.3    Stieber, P.4
  • 5
    • 77958162955 scopus 로고    scopus 로고
    • Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer
    • Holdenrieder, S.; Nagel, D.; Stieber, P. Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer. Cancer Biomark. 2010, 6, 179-190.
    • (2010) Cancer Biomark. , vol.6 , pp. 179-190
    • Holdenrieder, S.1    Nagel, D.2    Stieber, P.3
  • 6
    • 0024581504 scopus 로고
    • Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer
    • Jorgensen, L.G.; Hansen, H.H.; Cooper, E.H. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Eur. J. Cancer Clin. Oncol. 1989, 25, 123-128.
    • (1989) Eur. J. Cancer Clin. Oncol. , vol.25 , pp. 123-128
    • Jorgensen, L.G.1    Hansen, H.H.2    Cooper, E.H.3
  • 7
    • 79957528306 scopus 로고    scopus 로고
    • Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer
    • Petrovic, M.; Baskic, D.; Bankovic, D.; Ilic, N. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer. Biomarkers 2011, 16, 311-320.
    • (2011) Biomarkers , vol.16 , pp. 311-320
    • Petrovic, M.1    Baskic, D.2    Bankovic, D.3    Ilic, N.4
  • 9
    • 0029032851 scopus 로고
    • Preoperative CA 125: An independent prognostic factor in patients with stage I epithelial ovarian cancer
    • Nagele, F.; Petru, E.; Medl, M.; Kainz, C.; Graf, A.H.; Sevelda, P. Preoperative CA 125: An independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol. 1995, 86, 259-264.
    • (1995) Obstet Gynecol , vol.86 , pp. 259-264
    • Nagele, F.1    Petru, E.2    Medl, M.3    Kainz, C.4    Graf, A.H.5    Sevelda, P.6
  • 11
    • 79959610405 scopus 로고    scopus 로고
    • Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC)
    • Cedres, S.; Nunez, I.; Longo, M.; Martinez, P.; Checa, E.; Torrejón, D.; Felip, E. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC). Clin. Lung Cancer 2011, 12, 172-179.
    • (2011) Clin. Lung Cancer , vol.12 , pp. 172-179
    • Cedres, S.1    Nunez, I.2    Longo, M.3    Martinez, P.4    Checa, E.5    Torrejón, D.6    Felip, E.7
  • 12
    • 0019968599 scopus 로고
    • Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer
    • Kato, H.; Morioka, H.; Tsutsui, H.; Aramaki, S.; Torigoe, T. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer 1982, 50, 1294-1296.
    • (1982) Cancer , vol.50 , pp. 1294-1296
    • Kato, H.1    Morioka, H.2    Tsutsui, H.3    Aramaki, S.4    Torigoe, T.5
  • 13
    • 48049105367 scopus 로고    scopus 로고
    • A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer
    • Kagohashi, K.; Satoh, H.; Ishikawa, H.; Ohtsuka, M.; Sekizawa, K. A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer. Med. Oncol. 2008, 25, 187-189.
    • (2008) Med. Oncol. , vol.25 , pp. 187-189
    • Kagohashi, K.1    Satoh, H.2    Ishikawa, H.3    Ohtsuka, M.4    Sekizawa, K.5
  • 14
    • 0026660504 scopus 로고
    • Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma
    • Niklinski, J.; Furman, M.; Laudanski, J.; Kozlowski, M. Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma. Neoplasma 1992, 39, 279-282.
    • (1992) Neoplasma , vol.39 , pp. 279-282
    • Niklinski, J.1    Furman, M.2    Laudanski, J.3    Kozlowski, M.4
  • 16
    • 0037274950 scopus 로고    scopus 로고
    • Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer
    • Schneider, J.; Philipp, M.; Salewski, L.; Velcovsky, H.G. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer. Clin. Lab. 2003, 49, 35-42.
    • (2003) Clin. Lab. , vol.49 , pp. 35-42
    • Schneider, J.1    Philipp, M.2    Salewski, L.3    Velcovsky, H.G.4
  • 17
    • 0037314212 scopus 로고    scopus 로고
    • Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
    • Pujol, J.L.; Quantin, X.; Jacot, W.; Boher, J.M.; Grenier, J.; Lamy, P.J. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 2003, 39, 131-138.
    • (2003) Lung Cancer , vol.39 , pp. 131-138
    • Pujol, J.L.1    Quantin, X.2    Jacot, W.3    Boher, J.M.4    Grenier, J.5    Lamy, P.J.6
  • 18
    • 0035145078 scopus 로고    scopus 로고
    • Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: Prospective study in 621 patients
    • Pujol, J.L.; Boher, J.M.; Grenier, J.; Quantin, X. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: Prospective study in 621 patients. Lung Cancer 2001, 31, 221-231.
    • (2001) Lung Cancer , vol.31 , pp. 221-231
    • Pujol, J.L.1    Boher, J.M.2    Grenier, J.3    Quantin, X.4
  • 19
  • 20
    • 29244489499 scopus 로고    scopus 로고
    • The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer
    • Nisman, B.; Heching, N.; Biran, H.; Barak, V.; Peretz, T. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer. Tumour. Biol. 2006, 27, 8-16.
    • (2006) Tumour. Biol. , vol.27 , pp. 8-16
    • Nisman, B.1    Heching, N.2    Biran, H.3    Barak, V.4    Peretz, T.5
  • 21
    • 17744389363 scopus 로고    scopus 로고
    • Association d'Enseignement et de Recherche des Internes en Oncologie. Brain metastases at the time of presentation of non-small cell lung cancer: A multi-centric AERIO analysis of prognostic factors
    • Jacot, W.; Quantin, X.; Boher, J.M.; Andre, F.; Moreau, L.; Gainet, M.; Depierre, A.; Quoix, E.; Chevalier T.L.; Pujol, J.L. Association d'Enseignement et de Recherche des Internes en Oncologie. Brain metastases at the time of presentation of non-small cell lung cancer: A multi-centric AERIO analysis of prognostic factors. Br. J. Cancer 2001, 84, 903-909.
    • (2001) Br. J. Cancer , vol.84 , pp. 903-909
    • Jacot, W.1    Quantin, X.2    Boher, J.M.3    Andre, F.4    Moreau, L.5    Gainet, M.6    Depierre, A.7    Quoix, E.8    Chevalier, T.L.9    Pujol, J.L.10
  • 22
    • 0036257505 scopus 로고    scopus 로고
    • Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer
    • Reinmuth, N.; Brandt, B.; Semik, M.; et al. Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer. Lung Cancer 2002, 36, 265-270.
    • (2002) Lung Cancer , vol.36 , pp. 265-270
    • Reinmuth, N.1    Brandt, B.2    Semik, M.3
  • 23
  • 26
    • 0042529193 scopus 로고    scopus 로고
    • Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer
    • Gaspar, M.J.; Diez, M.; Rodriguez, A.; Ratia, T.; Martin, D.A.; Galvan, M.; Granell, J.; Coca, C. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Anticancer Res. 2003, 23, 3427-3432.
    • (2003) Anticancer Res. , vol.23 , pp. 3427-3432
    • Gaspar, M.J.1    Diez, M.2    Rodriguez, A.3    Ratia, T.4    Martin, D.A.5    Galvan, M.6    Granell, J.7    Coca, C.8
  • 27
    • 67651152754 scopus 로고    scopus 로고
    • Increased serum CA-125 levels in patients with lung cancer post thoracotomy
    • Nuñez, G.R.; Ito, C.; Del Giglio, A. Increased serum CA-125 levels in patients with lung cancer post thoracotomy. South Med. J. 2009, 102, 427-428.
    • (2009) South Med. J. , vol.102 , pp. 427-428
    • Nuñez, G.R.1    Ito, C.2    del Giglio, A.3
  • 29
    • 35748940008 scopus 로고    scopus 로고
    • Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer
    • Mizuguchi, S.; Nishiyama, N.; Iwata, T.; Nishida, T.; Izumi, N.; Tsukioka, T.; Inoue, K.; Uenishi, T.; Wakasa, K.; Suehiro, S. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Lung Cancer 2007, 58, 369-375.
    • (2007) Lung Cancer , vol.58 , pp. 369-375
    • Mizuguchi, S.1    Nishiyama, N.2    Iwata, T.3    Nishida, T.4    Izumi, N.5    Tsukioka, T.6    Inoue, K.7    Uenishi, T.8    Wakasa, K.9    Suehiro, S.10
  • 32
    • 34447268726 scopus 로고    scopus 로고
    • Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib
    • Chiu, C.H.; Shih, Y.N.; Tsai, C.M.; Liou, J.L.; Chen, Y.M.; Perng, R.P. Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib. Lung Cancer 2007, 57, 213-221.
    • (2007) Lung Cancer , vol.57 , pp. 213-221
    • Chiu, C.H.1    Shih, Y.N.2    Tsai, C.M.3    Liou, J.L.4    Chen, Y.M.5    Perng, R.P.6
  • 33
    • 84862844389 scopus 로고    scopus 로고
    • The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited
    • Ma, S.; Shen, L.; Qian, N.; Chen, K. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. Cancer Biomark. 2011-2012, 10, 155-162.
    • (2011) Cancer Biomark , vol.10 , pp. 155-162
    • Ma, S.1    Shen, L.2    Qian, N.3    Chen, K.4
  • 34
    • 84865431357 scopus 로고    scopus 로고
    • Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer
    • Tomita, M.; Shimizu, T.; Ayabe, T.; Onitsuka, T. Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer. Asia Pac. J. Clin. Oncol. 2012, 8, 244-247.
    • (2012) Asia Pac. J. Clin. Oncol. , vol.8 , pp. 244-247
    • Tomita, M.1    Shimizu, T.2    Ayabe, T.3    Onitsuka, T.4
  • 35
    • 84859435256 scopus 로고    scopus 로고
    • Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
    • Grunnet, M.; Sorensen, J.B. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer 2012, 76, 138-143.
    • (2012) Lung Cancer , vol.76 , pp. 138-143
    • Grunnet, M.1    Sorensen, J.B.2
  • 36
    • 35348885056 scopus 로고    scopus 로고
    • Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer
    • Cho, W.C. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed. Pharmacother. 2007, 61, 515-519.
    • (2007) Biomed. Pharmacother. , vol.61 , pp. 515-519
    • Cho, W.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.